Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Chikungunya Fever - Overview Chikungunya Fever - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Chikungunya Fever - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Chikungunya Fever - Companies Involved in Therapeutics Development Bharat Biotech International Ltd Ennaid Therapeutics LLC Etubics Corp Globavir Biosciences Inc Hawaii Biotech Inc Indian Immunologicals Ltd Inovio Pharmaceuticals Inc Integral Molecular Inc Integrated BioTherapeutics Inc Moderna Therapeutics Inc Mymetics Corp Paradigm Biopharmaceuticals Ltd PaxVax Inc Profectus BioSciences Inc Shionogi & Co Ltd Takeda Pharmaceutical Co Ltd Themis Bioscience GmbH Valneva SE Vaxart Inc Chikungunya Fever - Drug Profiles (chikungunya + Zika) (bivalent) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress BBV-87 - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya (viral like particles) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya (virus like particle) vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress chikungunya vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress CIL-15001 - Drug Profile Product Description Mechanism Of Action R&D Progress GBV-006 - Drug Profile Product Description Mechanism Of Action R&D Progress Gene Therapy for Chikungunya - Drug Profile Product Description Mechanism Of Action R&D Progress HSRx-431 - Drug Profile Product Description Mechanism Of Action R&D Progress IMCKV-063 - Drug Profile Product Description Mechanism Of Action R&D Progress Monoclonal Antibodies for Chikungunya - Drug Profile Product Description Mechanism Of Action R&D Progress Monoclonal Antibodies for Equine Encephalitis and Chikungunya - Drug Profile Product Description Mechanism Of Action R&D Progress Monoclonal Antibodies to Inhibit CHIKV E2 for Chikungunya - Drug Profile Product Description Mechanism Of Action R&D Progress mRNA-1388 - Drug Profile Product Description Mechanism Of Action R&D Progress mRNA-1944 - Drug Profile Product Description Mechanism Of Action R&D Progress MV-CHIK - Drug Profile Product Description Mechanism Of Action R&D Progress pentosan polysulfate sodium - Drug Profile Product Description Mechanism Of Action R&D Progress Peptides for Infectious Diseases - Drug Profile Product Description Mechanism Of Action R&D Progress SCV-1002 - Drug Profile Product Description Mechanism Of Action R&D Progress SCV-305 - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecule to Inhibit NS4 for Chikungunya Fever - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for Chikungunya - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for Chikungunya - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for Chikungunya Fever - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for Chikungunya Fever - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for Infectious Disease - Drug Profile Product Description Mechanism Of Action R&D Progress SVIR-001 - Drug Profile Product Description Mechanism Of Action R&D Progress Synthetic Peptides for Chikungunya - Drug Profile Product Description Mechanism Of Action R&D Progress TAK-507 - Drug Profile Product Description Mechanism Of Action R&D Progress Tatbeclin-1 - Drug Profile Product Description Mechanism Of Action R&D Progress VLA-1553 - Drug Profile Product Description Mechanism Of Action R&D Progress Chikungunya Fever - Dormant Projects Chikungunya Fever - Product Development Milestones Featured News & Press Releases Mar 27, 2018: World-first technology developed by Australian biotech company set to revolutionize global vaccine industry Mar 13, 2018: VALNEVA Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Nov 06, 2017: Themis to Present Phase 2 Interim Results for Chikungunya Vaccine Candidate at ASTMH 2017 Annual Meeting Sep 05, 2017: Chikungunya Vaccine Development Towards Phase III Trials Boosted by Innovate UK Jul 27, 2017: Themis Bioscience Starts Phase II Clinical Study in Endemic Area Jun 05, 2017: Bharat Biotech Begins Phase I Trial of Chikungunya Vaccine Jun 05, 2017: NIAID-Sponsored Trial of Experimental Chikungunya Vaccine Begins Mar 07, 2017: The Australian Company Testing a Breakthrough Treatment for Ross River Jan 09, 2017: Profectus BioSciences Bivalent Vaccine Protects Animals from Infection and Death After Exposure to Chikungunya or Zika Virus Dec 19, 2016: UTMB researchers develop first chikungunya vaccine from virus that does not affect people Aug 30, 2016: Hawaii Biotech Awarded Grant To Develop Chikungunya Virus Vaccine Aug 25, 2016: Leading Chikungunya Vaccine in Clinical Trial Phase 2 Mar 22, 2016: Inovio’s DNA-based Monoclonal Antibody and DNA Vaccine Provide 100% Protection Against Lethal Chikungunya Virus Challenge in Preclinical Study Mar 02, 2015: Themis Bioscience’s Chikungunya Vaccine Study Results Published in The Lancet Infectious Diseases Dec 10, 2014: Integral Molecular identifies potent inhibitory antibodies against Chikungunya virus Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer

List of Tables Number of Products under Development for Chikungunya Fever, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Products under Development by Companies, H1 2018 Products under Development by Companies, H1 2018 (Contd..1), H1 2018 Products under Development by Universities/Institutes, H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Chikungunya Fever - Pipeline by Bharat Biotech International Ltd, H1 2018 Chikungunya Fever - Pipeline by Ennaid Therapeutics LLC, H1 2018 Chikungunya Fever - Pipeline by Etubics Corp, H1 2018 Chikungunya Fever - Pipeline by Globavir Biosciences Inc, H1 2018 Chikungunya Fever - Pipeline by Hawaii Biotech Inc, H1 2018 Chikungunya Fever - Pipeline by Indian Immunologicals Ltd, H1 2018 Chikungunya Fever - Pipeline by Inovio Pharmaceuticals Inc, H1 2018 Chikungunya Fever - Pipeline by Integral Molecular Inc, H1 2018 Chikungunya Fever - Pipeline by Integrated BioTherapeutics Inc, H1 2018 Chikungunya Fever - Pipeline by Moderna Therapeutics Inc, H1 2018 Chikungunya Fever - Pipeline by Mymetics Corp, H1 2018 Chikungunya Fever - Pipeline by Paradigm Biopharmaceuticals Ltd, H1 2018 Chikungunya Fever - Pipeline by PaxVax Inc, H1 2018 Chikungunya Fever - Pipeline by Profectus BioSciences Inc, H1 2018 Chikungunya Fever - Pipeline by Shionogi & Co Ltd, H1 2018 Chikungunya Fever - Pipeline by Takeda Pharmaceutical Co Ltd, H1 2018 Chikungunya Fever - Pipeline by Themis Bioscience GmbH, H1 2018 Chikungunya Fever - Pipeline by Valneva SE, H1 2018 Chikungunya Fever - Pipeline by Vaxart Inc, H1 2018 Chikungunya Fever - Dormant Projects, H1 2018 List of Figures Number of Products under Development for Chikungunya Fever, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Number of Products by Top 10 Targets, H1 2018 Number of Products by Stage and Top 10 Targets, H1 2018 Number of Products by Mechanism of Actions, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Top 10 Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018

Bharat Biotech International Ltd Ennaid Therapeutics LLC Etubics Corp Globavir Biosciences Inc Hawaii Biotech Inc Indian Immunologicals Ltd Inovio Pharmaceuticals Inc Integral Molecular Inc Integrated BioTherapeutics Inc Moderna Therapeutics Inc Mymetics Corp Paradigm Biopharmaceuticals Ltd PaxVax Inc Profectus BioSciences Inc Shionogi & Co Ltd Takeda Pharmaceutical Co Ltd Themis Bioscience GmbH Valneva SE Vaxart Inc